Advanced Solid Malignant Tumors Clinical Trial
Official title:
Phase 1, Open Label Study to Assess the Safety and Pharmacokinetics of DS-5573a in Japanese Patients With Advanced Solid Malignant Tumors
This is an open-label, sequential dose escalation and expansion study to evaluate the safety, and pharmacokinetics of DS-5573a in Japanese patients with advanced solid malignant tumors.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02690337 -
Study of DS-1123a in Advanced Solid Tumours
|
Phase 1 | |
Completed |
NCT01290471 -
Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors
|
Phase 1 | |
Completed |
NCT02675491 -
Phase 1 Study of DS-6051b in Japanese Subjects With Advanced Solid Malignant Tumors
|
Phase 1 |